CoChat

C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts

Open access
Mitta, Vinod P., Christen, William G., Glynn, Robert J., Semba, Richard D., Ridker, Paul M., Rimm, Eric B., Hankinson, Susan E., Schaumberg, Debra A. · 2013 · JAMA Ophthalmology
Cited by 74

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

IMPORTANCE: This study adds to the evidence that elevated levels of high-sensitivity C-reactive protein (hsCRP) predict future risk of age-related macular degeneration (AMD). This information might shed light on underlying pathological mechanisms involving inflammation and could be of clinical utility in the identification of persons at high risk of AMD who may benefit from increased adherence to lifestyle recommendations, eye examination schedules, and therapeutic protocols. OBJECTIVE: To investigate the relationship between hsCRP and future risk of AMD in US men and women. DESIGN: Pooled analysis of prospective nested case-control data from the Women's Health Study and 4 other cohorts, the Physicians' Health Study, Women's Antioxidant and Folic Acid Cardiovascular Study, Nurses' Health Study, and Health Professionals Follow-up Study. SETTING: A prospective nested case-control study within 5 large cohorts. PARTICIPANTS: Patients were initially free of AMD. We prospectively identified 647 incident cases of AMD and selected age- and sex-matched controls for each AMD case (2 controls for each case with dry AMD or 3 controls for each case of neovascular AMD). MAIN OUTCOME MEASURES We measured hsCRP in baseline blood samples. We used conditional logistic regression models to examine the relationship between hsCRP and AMD and pooled findings using meta-analytic techniques. RESULTS: After adjusting for cigarette smoking status, participants with high (>3 mg/L) compared with low (<1 mg/L) hsCRP levels had cohort-specific odds ratios (ORs) for incident AMD ranging from 0.94 (95% CI, 0.58-1.51) in the Physicians' Health Study to 2.59 (95% CI, 0.58-11.67) in the Women's Antioxidant and Folic Acid Cardiovascular Study. After testing for heterogeneity between studies (Q = 5.61; P = .23), we pooled findings across cohorts and observed a significantly increased risk of incident AMD for high vs low hsCRP levels (OR, 1.49; 95% CI, 1.06-2.08). Risk of neovascular AMD was also increased among those with high hsCRP levels (OR, 1.84; 95% CI, 1.14-2.98). CONCLUSIONS AND RELEVANCE: Overall, these pooled findings from 5 prospective cohorts add further evidence that elevated levels of hsCRP predict greater future risk of AMD. This information might shed light on underlying mechanisms and could be of clinical utility in the identification of persons at high risk of AMD who may benefit from increased adherence to lifestyle recommendations, eye examination schedules, and therapeutic protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaophthalmol.2013.2303

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 74

Metadata

Authors
Mitta, V. P., Christen, W. G., Glynn, R. J., Semba, R. D., Ridker, P. M., Rimm, E. B., Hankinson, S. E., & Schaumberg, D. A.
Venue
JAMA Ophthalmology
Published
2013-04-01
Volume
131
Issue
4
Pages
507
ISSN
2168-6165 (ISSN-L)
OpenAlex
W2080381438
Cited by
74
References
21
FWCI
5.42
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts. https://app.cochat.ai/papers/10.1001/jamaophthalmol.2013.2303
The paper
Mitta, V. P., Christen, W. G., Glynn, R. J., Semba, R. D., Ridker, P. M., Rimm, E. B., Hankinson, S. E., & Schaumberg, D. A. (2013). C-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts. JAMA Ophthalmology. https://doi.org/10.1001/jamaophthalmol.2013.2303

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.